Actionable news
0
All posts from Actionable news
Actionable news in RGLS: Regulus Therapeutics Inc.,

Regulus Therapeutics Inc.

GO

Average Recommendation: Buy Average Target Price: 28.00
Number of Ratings: 5 Current Quarters Estimate: -0.37
FY Report Date: 12 / 2015 Current Year's Estimate: -1.36
Last Quarter's Earnings: -0.41 Median PE on CY...

More